Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin.

Authors:
Yu S; Ren X; Li L.

Journal:
Exp Hematol Oncol

Publication Year: 2022

DOI:
10.1186/s40164-022-00296-9

PMCID:
PMC9295421

PMID:
35854339

Journal Information

Full Title: Exp Hematol Oncol

Abbreviation: Exp Hematol Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential competing interest. Competing interests The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential competing interest."

Evidence found in paper:

"Funding Not applicable."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025